Replies to post #233080 on Biotech Values

[Whalatane]

dewophile No by all means please "butt in " ...thats why I read this board ...for informed views.
What I read was

Results: Twelve patients were treated with lenzilumab. Clinical improvement was observed in 11 out of 12 (92%), with a median time to discharge of 5 days. There was a significant improvement in oxygenation: The proportion of patients with SpO2/FiO2 < 315 at the end of observation was 8% vs. compared to 67% at baseline (p=0.00015). A significant improvement in mean CRP and IL-6 values on day 3 following lenzilumab administration was also observed (137.3 mg/L vs 51.2 mg/L, p = 0.040; 26.8 pg/mL vs 16.1 pg/mL, p = 0.035; respectively

Can you link me to what you were reading .
thx
Are you saying that because there was no placebo arm there's no way to know if these results are better than placebo ...unpowered study etc .

I agree ..a lot of limitations re the study
Kiwi

PS. Their P 3 double blinded placebo controlled trial is underway ...with an interim analysis ...so we should have some conclusive data fairly soon ...before yr end

[Whalatane]

dewophile ...found the link. thx ...HGEN

https://9e234b13-0cc4-4c74-b924-d7874342289e.filesusr.com/ugd/6ca631_d3d65605599142889126b30cbd24ee64.pdf

Kiwi